Candel Therapeutics, Inc.
CADL
$4.95
-$0.10-1.89%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 119.73M | 86.96M | 100.69M | 92.17M | 102.65M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.66M | 3.17M | 2.92M | 983.00K | 1.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 121.39M | 90.13M | 103.61M | 93.15M | 103.80M |
|
|
|||||
| Total Current Assets | 121.39M | 90.13M | 103.61M | 93.15M | 103.80M |
| Net Property, Plant & Equipment | 3.30M | 3.11M | 2.05M | 2.43M | 2.73M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 503.00K | 351.00K | 311.00K | 324.00K | 329.00K |
| Total Assets | 125.20M | 93.60M | 105.97M | 95.91M | 106.87M |
|
|
|||||
| Total Accounts Payable | 1.13M | 1.12M | 1.95M | 760.00K | 237.00K |
| Total Accrued Expenses | 6.87M | 5.09M | 4.05M | 2.41M | 4.72M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 445.00K | 4.66M | 7.30M | 9.75M | 10.46M |
| Total Finance Division Other Current Liabilities | 553.00K | 55.00K | 1.41M | 7.15M | 22.11M |
| Total Other Current Liabilities | 553.00K | 55.00K | 1.41M | 7.15M | 22.11M |
| Total Current Liabilities | 9.00M | 10.93M | 14.72M | 20.07M | 37.53M |
|
|
|||||
| Total Current Liabilities | 9.00M | 10.93M | 14.72M | 20.07M | 37.53M |
| Long-Term Debt | 47.13M | 973.00K | 939.00K | 904.00K | 2.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.46M | 1.57M | 104.00K | 257.00K | 407.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.69M | -- | -- | -- | -- |
| Total Liabilities | 73.27M | 13.47M | 15.76M | 21.23M | 40.54M |
|
|
|||||
| Common Stock & APIC | 282.76M | 281.46M | 280.28M | 259.95M | 258.98M |
| Retained Earnings | -230.39M | -200.89M | -189.62M | -184.83M | -192.21M |
| Treasury Stock & Other | -448.00K | -448.00K | -448.00K | -448.00K | -448.00K |
| Total Common Equity | 51.92M | 80.12M | 90.21M | 74.68M | 66.33M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 51.92M | 80.12M | 90.21M | 74.68M | 66.33M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 51.92M | 80.12M | 90.21M | 74.68M | 66.33M |
|
|
|||||